-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。WEC Energyは、第1四半期に堅調な業績を達成しました。調整後EPSは前年同期比7.9%増となり、市場予想を6.5%上回りました。売上高は9.0%増の34億3,000万ドル（市場予想比0.5%増）となり、これは料金値上げと緩やかな販売量増加によるものです。天候調整後の小売電力供給量は1.3%増加し、特に大口商業・産業顧客が2.7%増と大きく伸びました。一方、天然ガス供給量は温暖な気候の影響で3.5%減少しました。多様な公益事業ポートフォリオを持つWECは、データセンターや製造施設からの需要増加が2027年頃に加速すると予想される中で、有利な立場にあります。WECは、2026年のEPSガイダンスを5.51ドル～5.61ドルに据え置き、今後5年間で7%～8%のEPS成長率という市場予想に合致させました。設備投資は8億1,790万ドル（前年同期比16.7%増）と高水準を維持し、インフラ拡張を支えました。また、営業キャッシュフローは12億2,000万ドルに達し、設備投資と配当を十分にカバーしています。配当は1株当たり0.9525ドルと6.7%増額され、安定した収益と株主還元の実績を改めて示しました。
Related Articles
Australia
American Electric Power CEO Says Speed to Market Key Issue in Load Connection
American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%
$AEP
Australia
MGE Energy Q1 Earnings, Revenue Rise
MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%
$MGEE
Research
Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.
$PFE